Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT)
Crossref DOI link: https://doi.org/10.1007/s00520-016-3540-4
Published Online: 2016-12-28
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ades, Steven https://orcid.org/0000-0002-7077-1842
Halyard, M.
Wilson, K.
Ashikaga, T.
Heimann, R.
Kumar, S.
Blackstock, W.
Funding for this research was provided by:
Merck
License valid from 2016-12-28